1. News | 2014.12.11

   Malaria: formal identification of the artemisinin resistance gene

   Together with teams from Columbia University (USA), CNRS in Toulouse and NIH/NIAID (USA), Institut Pasteur scientists based in Paris and Cambodia have recently provided the key demonstration that K13 is indeed the main determinant of artemisinin resistance in Plasmodium falciparum parasites. This work is a landmark for the scientific community, as it provides a validated molecular marker for...

2. News | 2013.12.18

   Molecular marker discovered for detecting artemisinin-resistant forms of malaria

   Scientists at the Institut Pasteur in Paris and Cambodia, CNRS and NIH have identified a molecular marker for detecting malaria parasites with resistance to artemisinin derivatives Un marqueur moléculaire permettant de détecter les parasites du paludisme résistants aux dérivés de l’artémisinine, constituants majeurs des traitements antipaludiques actuellement recommandés par l’OMS, a...

3. News | 2013.12.12

   A prime target for the development of anti-inflammatories

   For the first time, scientists from the Institut Pasteur and Inserm have demonstrated the key role played by a particular molecule in intestinal infection.

4. News | 2013.12.11

   Carriers of a genetic mutation show increased dependence on tobacco

   Scientists at the Institut Pasteur, the French National Center for Scientific Research (CNRS) and Pierre and Marie Curie University (UPMC) have recently proven that, in mice, nicotine intake – nicotine is the main addictive substance in tobacco – is heavily regulated by a genetic mutation that is very common in humans. 

5. News | 2013.11.03

   Identification of a new mechanism in immunotherapy for lymphoma

   Using innovative dynamic imaging technique, scientists at the Institut Pasteur, Inserm and the VU Medical Center in Amsterdam have uncovered the mode of action of anti-CD20, an antibody therapy frequently used in the treatment of lymphomas (cancers of the immune system) as well as some auto-immune diseases. In a lymphoma model, the scientists have been able to carry out real time in vivo imaging...

6. News | 2013.11.04

   Two European programs reinforce the fight against emerging diseases

   The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...

7. News | 2013.10.09

   Fine-tuning the approach to malaria and toxoplasmosis research

   A study carried out by teams from the Institut Pasteur, the Institut Cochin (Inserm, CNRS, Paris Descartes University), and the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, may very well redefine current approaches to malaria and toxoplasmosis research in terms of treatment development. Their research which focuses on the role played by the protein AMA1 (present...

8. News | 2013.09.30

   Potential therapeutic targets for blocking AIDS virus replication

   Scientists from the Institut Pasteur and Inserm have identified several proteins in humans as potential new therapeutic targets for treating the AIDS virus. These proteins are part of a complex cellular mechanism that blocks the virus replication in cells called macrophages. The discovery of this mechanism and the proteins involved gives scientists a solid theoretical basis for developing new...

9. News | 2013.08.01

   Dengue: identifying mosquito genetic factors that control virus transmission

   Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...

10. News | 2013.05.28

    Worldwide Outbreak of Highly Antibiotic-Resistant Salmonella Risks Spreading to European Poultry Farms

    In a study published online May 28th for the Lancet Infectious Diseases medical journal, scientists at the Institut Pasteur in Paris and the Institut Pasteur in Morocco once again bring attention to the rapid worldwide spread of Salmonella Kentucky (S. Kentucky), a bacterium showing resistance to several classes of antibiotics. S. Kentucky is responsible for foodborne infections and has spread at...

Pages